Update 2000. Guidelines for prescribing psychoactive drugs

Geriatrics

Volumn 55, Issue 3, 2000, Pages 65-79

  Maletta, Gabe ^a,b   Mattox, Kimberly M ^c   Dysken, Maurice ^b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; LOXAPINE SUCCINATE; MESORIDAZINE; MESORIDAZINE BESYLATE; MOLINDONE; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERPHENAZINE; PHENELZINE; PROTRIPTYLINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TIOTIXENE; TRANYLCYPROMINE; TRAZODONE; TRIFLUOPERAZINE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; CLINICAL PROTOCOL; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG HALF LIFE; ELDERLY CARE; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; STEADY STATE;

AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; DOSAGE FORMS; GERIATRICS; HALF-LIFE; HUMANS;

EID: 0034055476     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rabins PV. Barriers to diagnosis and treatment of depression in elderly patients. Am J Geriatr Psychiatry 1996; 4(suppl 1):S79-83.
2. Larson E. Recognition of dementia: Discovering the silent epidemic. J Am Geriatr Soc 1998; 46(12):1576-7.
3. Williams-Russo P Barriers to diagnosis and treatment of depression in primary care settings. Am J Geriatr Psychiatry 1996; 4(supp.1):S84-S90.
4. Maletta G, Mattox KM, Dysken M. Guidelines for prescribing psychoactive drugs in the elderly: Part 1. Geriatrics 1991; 46:40-7.
5. Maletta G, Mattox KM, Dysken M. Guidelines for prescribing psychoactive drugs in the elderly: Part 2. Geriatrics 1991; 46:52-60.
6. Katz I. What should we do about undertreatment of late life psychiatric disorders in primary care? J Am Geriatr Soc 1998; 46:1573-5.
7. Psychotherapeutic agents. In: McEvoy GK (ed). AHFS Drug Information 99. Bethesda: American Society of Health-System Pharmacists, Inc, 1999:1894-2041.
8. CNS drugs. In: Kastrup EK (ed). Drug facts and comparisons. St. Louis: Facts and Comparisons, 1999:260-72.
9. Dipiro J (ed). Pharmacotherapy. A pathophysiologic approach. Stamford, CT: Appleton & Lange, 1997.
10. Gallo JJ, Marine S, Ford D, Anthony JC. Filters on the pathway to mental health care, II. Sociodemographic factors. Psychol Med 1995; 25:1149-60.
11. Caine ED, Lyness JM, Conwell Y. Diagnosis of late-life depression: Preliminary studies in primary care settings. Am J Geriatr Psychiatry 1996; 4(suppl 1):S45-S50.
12. Isometsa ER, Heikkinen ME, Marttunen MJ, et al. The last appointment before suicide: Is suicide intent communicated? Am J Psychiatry 1996; 152:919-22.
13. Lebowitz BD. Diagnosis and treatment of depression in late life: An overview of the NIH consensus statement. Am J Geriatr Psychiatry 1996; 4(suppl 1):S3-S6.
14. Papp LA, Sinha SS, Martinex JM, et al. Low-dose venlafaxine treatment in panic disorder. Psychopharmacol Bull 1997; 34:207-9.
15. Katz IR, Jeste D, Mintzer J, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J Clin Psychiatry 1999; 60(2):107-15.
16. Maletta G, Winegarden T. Reversal of anorexia by methylphenidate in apathetic severely demented nursing home patients. Am J Geriatr Psychiatry 1993; 1:23443.